BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10630664)

  • 21. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
    Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
    Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG subclass deficiency associated with corticosteroids in obstructive lung disease.
    Klaustermeyer WB; Gianos ME; Kurohara ML; Dao HT; Heiner DC
    Chest; 1992 Oct; 102(4):1137-42. PubMed ID: 1343817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of polymyalgia rheumatica.
    Espinoza LR; Vidal L; Pastor C
    Compr Ther; 1986 Sep; 12(9):19-23. PubMed ID: 3769419
    [No Abstract]   [Full Text] [Related]  

  • 25. Subcorneal pustulosis with combined lack of IgG/IgM and monoclonal gammopathy type IgA/Kappa.
    Rasch A; Schimmer M; Sander CA
    J Dtsch Dermatol Ges; 2009 Aug; 7(8):693-6. PubMed ID: 19243482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
    Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long-term treatment with efalizumab, but not with anti-TNF-α treatments or ustekinumab.
    Vilarrasa E; Puig L
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):609-11. PubMed ID: 24593678
    [No Abstract]   [Full Text] [Related]  

  • 28. Pleural and pericardial effusion in a patient with polymyalgia rheumatica.
    Jarana Aparicio I; Pedraza Serrano F; de Miguel Díez J
    Arch Bronconeumol; 2014 Aug; 50(8):370-1. PubMed ID: 24698397
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic neutrophilic leukemia associated with monoclonal gammopathy of undetermined significance.
    Ito T; Kojima H; Otani K; Komeno T; Mitsuhashi S; Hasegawa Y; Kobayashi T; Ninomiya H; Nagasawa T; Abe T
    Acta Haematol; 1996; 95(2):140-3. PubMed ID: 8638444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Summaries for patients. Giant-cell arteritis and polymyalgia rheumatica.
    Ann Intern Med; 2003 Sep; 139(6):I55. PubMed ID: 13679349
    [No Abstract]   [Full Text] [Related]  

  • 31. Papuloerythroderma associated with monoclonal gammopathy of undetermined significance.
    Fujimura T; Okuyama R; Ogawa E; Aiba S
    J Dermatol; 2009 Apr; 36(4):228-31. PubMed ID: 19348662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mass in corticosteroid treated patients with rheumatoid arthritis, asthma and polymyalgia rheumatica.
    Reid DM; Nicoll JJ; Brown N; Smith MA; Tothill P; Nuki G
    Scott Med J; 1985 Jan; 30(1):54-5. PubMed ID: 3983625
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence Analysis of Monoclonal Gammopathy of Undetermined Significance in People over 40 Years of Age].
    Zhang R; Wang L; Zhang ZH; Pang NN; Zhao JL; Qu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):623-628. PubMed ID: 30998181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polymyalgia rheumatica. A disease of elderly people].
    Rasenack U
    Med Klin; 1975 Mar; 70(11):452-5. PubMed ID: 1091829
    [No Abstract]   [Full Text] [Related]  

  • 35. IgG monoclonal gammopathy in four patients with polymyalgia rheumatica.
    Ilfeld D; Barzilay J; Vana D; Ben-Bassat M; Joshua H; Pick I
    Ann Rheum Dis; 1985 Jul; 44(7):501. PubMed ID: 4026411
    [No Abstract]   [Full Text] [Related]  

  • 36. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives.
    Ferraccioli GF; Di Poi E; Damato R
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S58-60. PubMed ID: 10948766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T
    Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome.
    Grimaldi D; Bartolucci P; Gouault-Heilmann M; Martin-Toutain I; Khellaf M; Godeau B
    Thromb Haemost; 2008 Apr; 99(4):782-3. PubMed ID: 18392339
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA; Wilson JR
    Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
    Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.